Compare HOFT & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOFT | STXS |
|---|---|---|
| Founded | 1924 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 143.7M | 139.3M |
| IPO Year | 1999 | 2004 |
| Metric | HOFT | STXS |
|---|---|---|
| Price | $13.02 | $1.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 42.2K | ★ 472.7K |
| Earning Date | 04-16-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.79% | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ 0.25 | N/A |
| Revenue | N/A | ★ $29,346,617.00 |
| Revenue This Year | $17.37 | $28.22 |
| Revenue Next Year | $9.00 | $30.47 |
| P/E Ratio | $52.56 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.62 | $1.24 |
| 52 Week High | $18.09 | $3.59 |
| Indicator | HOFT | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 39.55 |
| Support Level | $12.03 | N/A |
| Resistance Level | $13.71 | $1.96 |
| Average True Range (ATR) | 0.65 | 0.06 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 37.52 | 13.33 |
Hooker Furnishings Corp is a designer, marketer, and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality, and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segments: Hooker Branded segment, Domestic Upholstery segment, and All Other. It generates the majority of its revenue from the Hooker Branded segment.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.